IVD Contract research organizations provide support services to the biotechnology, companies throughout the development and commercialization of the product. Diagnostic instruments/equipment companies require various regulatory as well as testing services to implement product lifecycle. CROs are specifically designed to perform these services in order to reduce the in-house cost and time of the companies.
NAMSA and Proxima Clinical Research, Inc. – Notable Market Players in IVD Contract Research Organization Market
Market leaders operating in the market have undertaken various organic growth strategies in the IVD contract research organization market. The IVD contract research organization market majorly consists of players are Proxima Clinical Research, Inc., AKRN Scientific Consulting S.L. and ICON PLC. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaboration.
Below is the list of the growth strategies done by the players operating in the IVD contract research organization market:
| Company | Month & Year | Category | Description |
| Proxima Clinical Research, Inc. | Feb-2022 | Product News | Proxima Clinical Research (“Proxima CRO”), a company guiding emerging medical device and pharmaceutical companies from the earliest stages of product development through commercialization, announced today it has been honored with two gold awards and one honourable mention by AVA Digital Awards, an international creative competition honouring creative genius. |
| AKRN Scientific Consulting S.L. | Feb-2021 | Product News | The European Parliament adopted the proposal of the European Commission to amend the EU 2017/746 in vitro diagnostic medical device (IVD). This new position extends the IVDR transition timelines for manufacturers of certain IVDs, providing a progressive roll-out and aiming to avoid the disruption in the supply of IVDs to the European market. |
| ICON PLC | Sept-2020 | Product Launch | ICON plc, launched Accellacare a global clinical research network offering patients easier and faster access to creative treatments and offering customers the option to deploy decentralized trials. |
